BioPharma Reporter
NOVEMBER 16, 2023
The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project ideas to drive industry change.
Bio Pharma Dive
NOVEMBER 16, 2023
Clearance of Vertex Pharmaceuticals and CRISPR Therapeutics' Casgevy in the U.K. comes ahead of expected regulatory decisions in the U.S. and Europe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 16, 2023
Vertex and CRISPR's Casgevy has received conditional approval in the UK for treating sickle cell and transfusion-dependent beta-thalassemia.
Bio Pharma Dive
NOVEMBER 16, 2023
Red Tree Venture Capital plans to tap into San Diego’s biotech pipeline as it works to build a West Coast competitor to Boston-area investors.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
NOVEMBER 16, 2023
Ardelyx scores another FDA win after Xphyozah was approved by the FDA in October as an add-on therapy for chronic kidney disease patients.
Bio Pharma Dive
NOVEMBER 16, 2023
Acquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top sellers.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
NOVEMBER 16, 2023
The deal, which will result in a combined company operating under Q32's name, comes months after Homology laid off much of its staff and halted research.
Pharmaceutical Technology
NOVEMBER 16, 2023
The mRNA therapy may help to accelerate the regeneration of the urinary sphincter muscle, treating women with stress urinary incontinence.
Bio Pharma Dive
NOVEMBER 16, 2023
The company, which is working with regulators to lift a clinical hold, said the treatment could still help people with X-linked myotubular myopathy.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 16, 2023
Few people had probably heard of frontotemporal dementia until earlier this year, when the family of actor Bruce Willis announced the 68-year-old had been diagnosed with the condition. Frontotemporal dementia is a rare disease – thought to account for only one in every 20 cases of dementia.
Bio Pharma Dive
NOVEMBER 16, 2023
The 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer's therapy and muscular dystrophy drugs.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 16, 2023
On the occasion of National Ayurveda Day, the Ayurveda Medicine Manufacturers Association of India (AMMOI) has called upon the state governments that the constructive steps being taken by the Union Ayush Ministry to make Ayurveda system of treatment as an alternative treatment method for the world population should be taken forward by all state governments […]
Pharmaceutical Technology
NOVEMBER 16, 2023
Certa plans to discuss trial plans with the FDA in early 2024, with the trial set to begin later in the year.
Pharma Times
NOVEMBER 16, 2023
The bacteriocin development programme will first target pseudomonas aeruginosa - News - PharmaTimes
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Fierce Pharma
NOVEMBER 16, 2023
Micron nets nearly $24M from Gates Foundation to pioneer needle-free vaccine tech in low- and middle-income countries fkansteiner Thu, 11/16/2023 - 11:08
Pharma Times
NOVEMBER 16, 2023
The funding will be used to develop new diagnostic tests, treatments and devices - News - PharmaTimes
Pharmaceutical Technology
NOVEMBER 16, 2023
BT-7480 is under clinical development by Bicycle Therapeutics and currently in Phase II for Gastric Cancer.
Fierce Pharma
NOVEMBER 16, 2023
Watch out, Pfizer and Roche. Thanks to an acquisition and now an FDA approval, Bristol Myers Squibb is entering a niche lung cancer market. | Watch out, Pfizer and Roche. Thanks to an acquisition and now an FDA approval, Bristol Myers Squibb is entering a niche lung cancer market.
Pharmaceutical Technology
NOVEMBER 16, 2023
BT-7480 is under clinical development by Bicycle Therapeutics and currently in Phase II for Solid Tumor.
Fierce Pharma
NOVEMBER 16, 2023
Timothy Yap, Ph.D., used to see patients nearing the end of their cancer journey in his phase 1 department at the University of Texas' MD Anderson Cancer Center. | Cancer drugs are getting better thanks to innovation, driven by the data and regulatory forces like Project FrontRunner.
Pharmaceutical Technology
NOVEMBER 16, 2023
Augtyro (repotrectinib) is the only FDA-approved tumour kinase inhibitor (TKI) for ROS1-positive non-small cell lung cancer (NSCLC).
Fierce Pharma
NOVEMBER 16, 2023
Vertex, CRISPR gain 'historic' nod in UK for exa-cel. But will cost watchdogs embrace the gene-editing therapy?
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
NOVEMBER 16, 2023
The UK MHRA extended the licence of Vertex Pharmaceuticals’ cystic fibrosis drugs, Kaftrio and Kalydeco for children aged two to five years.
pharmaphorum
NOVEMBER 16, 2023
Life sciences inspections and investigations Mike.
Pharmaceutical Technology
NOVEMBER 16, 2023
LENZ Therapeutics has signed a definitive agreement with Graphite Bio to merge the two businesses in an all-stock deal.
pharmaphorum
NOVEMBER 16, 2023
In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at eClinical Solutions, about the ins and outs of successful AI implementation within pharma and healthcare.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
NOVEMBER 16, 2023
Astellas Pharma has signed an agreement for the acquisition of Propella Therapeutics in a deal worth $175m.
pharmaphorum
NOVEMBER 16, 2023
UK first to approve Vertex, CRISPR drug for blood disorders Phil.
BioSpace
NOVEMBER 16, 2023
The U.K.’s conditional marketing authorization for Vertex Pharmaceuticals and CRISPR Therapeutics’ gene-edited therapy exa-cel raises some potential safety concerns with the risk of off-target effects.
pharmaphorum
NOVEMBER 16, 2023
BMS gets US approval for ROS1 lung cancer drug Augtyro Phil.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
84 
Let's personalize your content